tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Neurotech International Ltd. (AU:NTI)
:NTI
Australian Market
NTI
Neurotech International Ltd.
Overview
Financials
Dividends
Technical Analysis
Chart
Earnings
Ownership
Similar Stocks
RESEARCH TOOLS
Top Analyst Stocks
Top Smart Score Stocks
Stock Screener
reports

Neurotech International Ltd. (NTI) Stock News & Sentiment

Compare
10 Followers
Neurotech International Reports Significant Loss Amid Increased R&D Investment
Premium
Company Announcements
Neurotech International Reports Significant Loss Amid Increased R&D Investment
4d ago
NTI
Neurotech Secures EMA Positive Opinion for NTI164 in Rett Syndrome
Premium
Company Announcements
Neurotech Secures EMA Positive Opinion for NTI164 in Rett Syndrome
4d ago
NTI
Director of Neurotech International Ltd. Increases Stake with Options Acquisition
Premium
Company Announcements
Director of Neurotech International Ltd. Increases Stake with Options Acquisition
7d ago
NTI
Neurotech International Issues New Unquoted Equity Options
Premium
Company Announcements
Neurotech International Issues New Unquoted Equity Options
7d ago
NTI
Neurotech International Enhances Cannabinoid Drug Development Through New Partnership
Premium
Company Announcements
Neurotech International Enhances Cannabinoid Drug Development Through New Partnership
18d ago
NTI
Neurotech International Appoints New CEO with Incentive Plan
Premium
Company Announcements
Neurotech International Appoints New CEO with Incentive Plan
27d ago
NTI
Neurotech Bolsters Cash Position with $2.44 Million R&D Tax Incentive Refund
Premium
Company Announcements
Neurotech Bolsters Cash Position with $2.44 Million R&D Tax Incentive Refund
1M ago
NTI
More AU:NTI News >

NTI News on the Web

Neurotech receives positive opinion for orphan status in Rett Syndrome from European drug regulator
StockHead
Neutral
Neurotech International Reports Significant Loss Amid Increased R&D Investment
TipRanks News
Neutral
Neurotech inks European development deal for cannabinoid therapies
StockHead
Neutral
Neurotech International Enhances Cannabinoid Drug Development Through New Partnership
TipRanks News
Neutral
Rare opportunities – ASX health stocks tackling unmet medical needs
StockHead
Neutral
ASX Lunch Wrap: ASX and gold reset record highs; but Origin cuts its LNG forecast
StockHead
Neutral
Neurotech International to Expire Listed Options in January
TipRanks News
Neutral
Is There Now An Opportunity In Neurotech International Limited ?
Yahoo Finance AU
Neutral

News Score - Last 7 Days

Neutral
AU:NTI
Sector Average
Media Buzz
This Week2 articles
Weekly Average1.25 articles
News Sentiment
This Week59%
Sector Average55%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is AU:NTI’s Media Buzz Sentiment?
2 articles about AU:NTI were published this week. In an average week, 1.25 articles are published.
    What is AU:NTI’s weekly average amount of articles?
    In an average week, 1.25 articles about AU:NTI are published.
      What is AU:NTI’s News Sentiment?
      59% of articles about AU:NTI were positive this week, compared to its sector average of 55%.
        Healthcare Stocks that are Trending in the News
        CADLCandel Therapeutics
        CORTCorcept Therapeutics
        CCCCC4 Therapeutics
        CTECConvaTec
        TMDXTransMedics Group
        Showing the stocks with the most bullish news sentiment over the past week

        Become an Expert with TipRanks Premium

        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis
        Subscribe NowSee Plans & Pricing